Image of Maha Reda Farhat

Maha Reda Farhat, M.D., M.D.,C.M.

617-432-4598

Maha Farhat  holds an MD from the McGill University Faculty of Medicine and a MSc in biostatistics from the Harvard Chan School of Public Health. She is also a practicing physician at the Massachusetts General Hospital Division of Pulmonary and Critical Care Medicine.

Program in Global Surgery and Social Change

Dr. Farhat's research focuses on the development and application of methods for associating genotype and phenotype in infectious disease pathogens, with a strong emphasis on translation to better diagnostics and surveillance in resource-poor settings. To date, Farhat's work has focused on the pathogen Mycobacterium tuberculosis and spans the spectrum from computational analysis to field studies. She is PI and Co-Investigator on several large projects funded by NIH including the NIAID and the BD2K initiative.


DBMI Research Areas
DBMI Courses
Pitfalls of bacterial pan-genome analysis approaches: a case study of M. tuberculosis and two less clonal bacterial species.
Authors: Authors: Marin MG, Quinones-Olvera N, Wippel C, Behruznia M, Jeffrey BM, Harris M, Mann BC, Rosenthal A, Jacobson KR, Warren RM, Li H, Meehan CJ, Farhat MR.
Bioinformatics
View full abstract on Pubmed
Genome-Wide Association Study Identifies a Locus at 17p13 to Be Associated With Intestinal Malrotation.
Authors: Authors: Gaitanidis A, Christensen MA, Dorken Gallastegi A, Breen KA, Velmahos GC, Kaafarani HMA, Farhat MR.
World J Surg
View full abstract on Pubmed
Complete genome sequence of a virulent barcoded Mycobacterium tuberculosis str. Erdman commonly used for non-human primate infection studies.
Authors: Authors: Marin MG, Chase MR, Quinones N, Wakabayashi S, Mugahid D, Fortune SM, Farhat MR, Chao MC.
Microbiol Resour Announc
View full abstract on Pubmed
Multivariable regression models improve accuracy and sensitive grading of antibiotic resistance mutations in Mycobacterium tuberculosis.
Authors: Authors: Kulkarni SG, Laurent S, Miotto P, Walker TM, Chindelevitch L, Nathanson CM, Ismail N, Rodwell TC, Farhat MR.
Nat Commun
View full abstract on Pubmed
Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis.
Authors: Authors: Tzelios CA, Malatesta S, Carney T, White LF, Weber SE, Thomson S, Theron D, Myers B, Parry CDH, Warren RM, Horsburgh CR, Farhat MR, Jacobson KR.
Clin Infect Dis
View full abstract on Pubmed
Frequently arising ESX-1-associated phase variants influence Mycobacterium tuberculosis fitness in the presence of host and antibiotic pressures.
Authors: Authors: Luna MJ, Oluoch PO, Miao J, Culviner P, Papavinasasundaram K, Jaecklein E, Shell SS, Ioerger TR, Fortune SM, Farhat MR, Sassetti CM.
mBio
View full abstract on Pubmed
Phyla: Towards a foundation model for phylogenetic inference.
Authors: Authors: Shen A, Ektefaie Y, Jain L, Farhat M, Zitnik M.
bioRxiv
View full abstract on Pubmed
Precision phenotyping for curating research cohorts of patients with unexplained post-acute sequelae of COVID-19.
Authors: Authors: Azhir A, Hügel J, Tian J, Cheng J, Bassett IV, Bell DS, Bernstam EV, Farhat MR, Henderson DW, Lau ES, Morris M, Semenov YR, Triant VA, Visweswaran S, Strasser ZH, Klann JG, Murphy SN, Estiri H.
Med
View full abstract on Pubmed
A Genome-wide Association Study Reveals a Novel Susceptibility Locus for Pancreas Divisum at 3q29.
Authors: Authors: Gaitanidis A, Christensen MA, Breen KA, Kambadakone AR, Joshipura ND, Fernandez-Del Castillo C, Hernandez-Barco YG, Kaafarani HMA, Velmahos GC, Farhat MR, Fagenholz PJ.
J Surg Res
View full abstract on Pubmed
Erratum for Poonawala et al., "Transcriptomic responses to antibiotic exposure in Mycobacterium tuberculosis".
Authors: Authors: Poonawala H, Zhang Y, Kuchibhotla S, Green AG, Cirillo DM, Di Marco F, Spitaleri A, Miotto P, Farhat MR.
Antimicrob Agents Chemother
View full abstract on Pubmed